İnsan çevirisi örneklerinden çeviri yapmayı öğrenmeye çalışıyor.
Profesyonel çevirmenler, işletmeler, web sayfaları ve erişimin serbest olduğu çeviri havuzlarından.
seetõttu ei soovitata ravimi subkutaanset manustamist kroonilise neerupudulikkusega patsientidele.
therefore, the sc route is not recommended for patients with ckd
Son Güncelleme: 2012-04-11
Kullanım Sıklığı: 1
Kalite:
koolitusjuhendis peab sisalduma alljärgnev oluline teave. • alfaepoetiini sisaldavate ravimite kasutamine võib põhjustada immunogeensust, mis viib harvadel juhtudel isoleeritud erütrotsütaarse aplaasiani. • teiste epoetiinravimitega suureneb ravimi subkutaansel manustamisel immunogeensusoht kroonilise neerupuudulikkuse korral. • puuduvad piisavad andmed abseamedi kohta, et teada ükskõik millise suurenenud immunogeensusohu ulatust ravimi subkutaansel kasutamisel. • seetõttu ei soovitata ravimi subkutaanset manustamist kroonilise neerupudulikkusega patsientidele. • tõhususe puudumist või muid immunogeensuse sümptomeid tuleb uurida. • müügiloa hoidjat tuleb teavitada igast oletatavast isoleeritud erütrotsütaarse aplaasia või immunogeensuse tekkimise juhust.
the educational leaflet shall contain the following key elements: • that the use of epoetin alfa products can cause immunogenicity which in rare cases may lead to pure red cell aplasia (prca) • that with other epoetin products, the risk of immunogenicity in chronic kidney disease (ckd) is increased with the subcutaneous (sc) route. • there is insufficient data on abseamed to know the size of any increased immunogenicity risk with subcutaneous use • therefore, the sc route is not recommended for patients with ckd • the loss of efficacy or other symptoms of the development of immunogenicity should be investigated • any suspected case of pure red cell aplasia or development of immunogenicity should be reported to the mah
Son Güncelleme: 2011-10-23
Kullanım Sıklığı: 1
Kalite:
Uyarı: Bu hizalama yanlış olabilir..
Böyle düşünüyorsanız lütfen silin.